Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats
about
Unprecedented therapeutic potential with a combination of A2A/NR2B receptor antagonists as observed in the 6-OHDA lesioned rat model of Parkinson's diseaseAdenosine receptors as drug targets--what are the challenges?Astrocytes and therapeutics for Parkinson's disease.Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration.Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders.Present and future drug treatment for Parkinson's disease.A(2A) Receptor Antagonism and Dyskinesia in Parkinson's DiseaseUncovering multiple molecular targets for caffeine using a drug target validation strategy combining A 2A receptor knockout mice with microarray profiling.Dual-target-directed drugs that block monoamine oxidase B and adenosine A(2A) receptors for Parkinson's diseaseNovel therapy in Parkinson's disease: adenosine A(2A) receptor antagonists.Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.Adenosine A2A antagonists in Parkinson's disease: what's next?A critical evaluation of behavioral rodent models of motor impairment used for screening of antiparkinsonian activity: The case of adenosine A(2A) receptor antagonists.Antiparkinsonian effects of the "Radiprodil and Tozadenant" combination in MPTP-treated marmosets.Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats.Adenosine A2A antagonism reverses levodopa-induced motor alterations in hemiparkinsonian rats.Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release.
P2860
Q28542729-890BB4EF-1D1D-4810-8321-9364D841004AQ29346491-2FB4E413-FC3E-4FAF-9961-A7A5A9C39FDBQ34168266-2A3339C8-09B6-4AD5-B25B-DD92E0BF42A5Q34191271-D01F4A1E-FD44-42DF-947C-2C39EC04A028Q34509861-0E22FA18-86FA-4F5C-9C12-0BF75B4811FFQ35484805-DD8991F4-1282-4C6A-8407-FC74402F1A88Q36057652-8A739BE5-D030-4ABA-A83F-31FB98651B0BQ37200611-C997348D-6DA1-40B9-9CE3-0DBF51529AD5Q37358676-1C744A51-E56A-4C33-90AB-284751DC0F02Q37844573-56E32AA0-624D-499F-85A8-4F2DA452AE11Q37924629-4B9031CE-0B56-49E4-AF93-11BB2E235B79Q38010070-DB603F77-4DC3-4627-A03C-1AA46C5A6B15Q38169996-2B0B9E12-79F4-4F1D-9EC8-805152BD4636Q38602173-E8334C1E-8F7C-4EB1-8548-6AB233E38D29Q43959920-3FC4A8BC-E710-45F3-B2E5-CBDF9BDCCFD4Q44175279-49BCA11E-9EC2-4D84-847B-8BA0789C634AQ44515045-EBEC120A-E0DC-42B0-8605-535026EFFF03
P2860
Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Motor stimulant effects of the ...... -hydroxydopamine-lesioned rats
@ast
Motor stimulant effects of the ...... -hydroxydopamine-lesioned rats
@en
Motor stimulant effects of the ...... -hydroxydopamine-lesioned rats
@nl
type
label
Motor stimulant effects of the ...... -hydroxydopamine-lesioned rats
@ast
Motor stimulant effects of the ...... -hydroxydopamine-lesioned rats
@en
Motor stimulant effects of the ...... -hydroxydopamine-lesioned rats
@nl
altLabel
Motor stimulant effects of the adenosine A
@nl
Motor stimulant effects of the ...... -hydroxydopamine-lesioned rats
@en
prefLabel
Motor stimulant effects of the ...... -hydroxydopamine-lesioned rats
@ast
Motor stimulant effects of the ...... -hydroxydopamine-lesioned rats
@en
Motor stimulant effects of the ...... -hydroxydopamine-lesioned rats
@nl
P2093
P2860
P1433
P1476
Motor stimulant effects of the ...... -hydroxydopamine-lesioned rats
@en
Motor stimulant effects of the ...... -hydroxydopamine-lesioned rats
@en
P2093
Annalisa Pinna
Micaela Morelli
Sandro Fenu
P2860
P356
10.1002/1098-2396(20010301)39:3<233::AID-SYN1004>3.0.CO;2-K
P407
P577
2001-03-01T00:00:00Z